Oncology Drugs
The latest news about Oncology Drugs: headlines, AI summaries and the full story from every source.
- HUTCHMED Reports Strong First-Half Earnings and Maintains Full-Year Guidance
- Johnson & Johnson Stock's Surge Was Foreshadowed by Strong Guidance and Oncology Growth
- Astrazeneca Reports Strong First-Half Performance Amid Mixed Pipeline Results
- Johnson & Johnson's Oncology Division Drives Growth Amid Dividend Stability
- Pfizer Q1 2026 Earnings Beat Estimates on Growth from Newer Drugs